Following the press release issued by Biogen regarding their plans on regulatory filing for Aducanumab in Alzheimer’s disease based on new analysis of larger dataset from Phase 3 studies, we are pleased to announce that these results will be presented… Continue Reading →
The intestinal microbiota is a key regulator of metabolic and immunological functions. The team of Bárcena and al. studied the role of the gut microbiota in the aging process and the physiopathology of Progeria (or Hutchinson-Gilford syndrome, characterized by… Continue Reading →
New analysis of larger dataset showed that aducanumab reduced clinical decline in patients with early Alzheimer’s disease as measured by the pre-specified primary and secondary endpoints Based on discussions with the FDA, the Company plans to submit a Biologics License… Continue Reading →
© 2025 Aging-news